DOI: https://doi.org/10.22141/2224-0713.6.92.2017.111591

Reversible cerebral vasoconstriction syndrome: clinical pattern, diagnosis and treatment

O.O. Kopchak

Abstract


The article presents review of the literature on clinical pattern, diagnosis and treatment of reversible cerebral vasoconstriction syndrome (RCVS). The main features of the clinical picture, diagnostic criteria of RCVS, therapeutic approaches and consequences of RCVS are considered. There is a description of the clinical case in a patient with subarachnoid hemorrhage associated with RCVS.

Keywords


reversible cerebral vasoconstriction syndrome; headache; diagnostic criteria; treatment

References


Ansari S.A., Rath TJ., Gandhi D. Reversible cerebral vasoconstriction syndromes presenting with subarachnoid hemorrhage: a case series // J. Neurointerv. Surg. — 2011. — 3. — P. 272-78.

Bain J., Segal D., Amin R. et al. Call-Fleming syndrome: headache in a 16-year-old girl // Pediatr. Neurol. — 2013. — 49. — P. 130 -33.

Calabrese L.H., Dodick D.W., Schwedt T.J. et al. Narrative review: reversible cerebral vasoconstriction syndromes // Ann. Intern. Med. — 2007. — 146. — P. 34-44.

Calic Z., Choong H., Schlaphoff G. et al. Reversible cerebral vasoconstriction syndrome following indomethacin // Cephalalgia. — 2014. — 34. — P. 1181-86.

Chen S.P., Chung Y.T., Liu T.Y. et al. Oxidative stress and increased formation of vasoconstricting F2-isoprostanes in patients with reversible cerebral vasoconstriction syndrome // Free Radic.

Biol. Med. — 2013. — 61. — P. 243-48.

Chen S.P., Fuh J.L., Chang F.C. et al. Transcranial color doppler study for reversible cerebral vasoconstriction syndromes //

Ann. Neurol. — 2008. — 63. — P. 751-57.

Chen S.P., Fuh J.L., Lirng J.F., Chang F.C., Wang S.J. Recurrent primary thunderclap headache and benign CNS angiopathy: spectra of the same disorder? // Neurology. — 2006. — 67. — P. 2164-69.

Chen S.P., Fuh J.L., Lirng J.F., Wang S.J. Hyperintense vessels on flair imaging in reversible cerebral vasoconstriction syndrome // Cephalalgia. — 2012. — 32. — P. 271-78.

Chen S.P., Fuh J.L., Wang S.J. et al. Brain-derived neurotrophic factor gene Val66Met polymorphism modulates reversible cerebral vasoconstriction syndromes // PLoS One. — 2011. — 6. — e18024.

Chen S.P., Fuh J.L., Wang S.J. et al. Magnetic resonance angiography in reversible cerebral vasoconstriction syndromes // Ann. Neurol. — 2010. — 67. — P. 648-56.

Chen S.P., Fuh J.L., Wang S.J. Reversible cerebral vasoconstriction syndrome: an under-recognized clinical emergency // Ther. Adv. Neurol. Disord. — 2010. — 3. — P.161-71.

Chen T.-Y., Winkelman J.W., Mao W.-C. The Use of Benzodiazepine Receptor Agonists and the Risk of Hospitalization for Pneumonia: A Nationwide Population-Based Nested Case-Control Study //

Chest. — 2017. i: S0012-3692(17)31326-0. doi: 10.1016/j.chest.2017.07.030.

Connolly K.R., Thase M.E. Emerging drugs for major depressive disorder // Expert. Opin. Emerging. Drugs. — 2012. — 17(1). — P. 105-126.

Cusack B., Nelson A., Richelson E. Binding of antidepressants to human brain receptors: focus on newer generation compounds // Psychopharmacology. — 1994. — 114. — P. 559-564.

Ducros A., Boukobza M., Porcher R. et al. The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome: a prospective series of 67 patients // Brain. — 2007. — 130. — P. 3091-101.

Ducros A., Bousser M.G. Reversible cerebral vasoconstriction syndrome // Pract. Neurol. — 2009. — 9. — P. 256-67.

Ducros A., Fiedler U., Porcher R. et al. Hemorrhagic manifestations of reversible cerebral vasoconstriction syndrome: frequency, features, and risk factors // Stroke. — 2010. — 41. — P. 2505-11.

Ducros A. L37: reversible cerebral vasoconstriction syndrome — distinction from CNS vasculitis // Presse Med. — 2013. — 42(4 pt 2). — P. 602-04.

Ducros A. Reversible cerebral vasoconstriction syndrome // Lancet Neurol. — 2012. — 11. — P. 906-17.

Edlow B.L., Kasner S.E., Hurst R.W., Weigele J.B., Levine J.M. Reversible cerebral vasoconstriction syndrome associated with subarachnoid hemorrhage // Neurocrit Care. — 2007. — 7. — P. 203-10.

Generalised anxiety disorder and panic disorder in adults: management National Institute for Health and Care Excellence. — London: NICE, 2011.

Grooters G.S., Sluzewski M., Tijssen C.C. How often is thunderclap headache caused by the reversible cerebral vasoconstriction syndrome? // Headache. — 2014. — 54. — P. 732-35.

Gupta S., Zivadinov R., Ramasamy D. et al. Reversible cerebral vasoconstriction syndrome (RCVS) in antiphospholipid antibody syndrome (APLA): the role of centrally acting vasodilators — case series and review of literature // Clin. Rheumatol. — 2014. — 33. — P. 1829-33.

Hajj-Ali R.A., Furlan A., Abou-Chebel A., Calabrese L.H. Benign angiopathy of the central nervous system: cohort of 16 patients with clinical course and long-term followup // Arthritis Rheum. — 2002. — 47. — P. 662-69.

Headache Classification Committee of the International Head­ache Society (IHS). The International Classification of Head­ache Disorders, 3rd edition (beta version) // Cephalalgia. — 2013. — 33. — P. 629-808.

Hu C.M., Lin Y.J., Fan Y.K., Chen S.P., Lai T.H. Isolated thunderclap headache during sex: orgasmic headache or reversible cerebral vasoconstriction syndrome? // J Clin Neurosci. — 2010. —

— P. 1349-51.

Jackson M., Lennox G., Jaspan T., Jefferson D. Migraine angiitis precipitated by sex headache and leading to watershed infarction // Cephalalgia. — 1993. — 13. — P. 427-30.

John S., Singhal A.B., Calabrese L. et al. Long-term outcomes after reversible cerebral vasoconstriction syndrome // Cephalalgia. — 2016. — 36(4). — P. 387-94.

Kim T., Ahn Sh., Sohn C.H. et al. Reversible cerebral vasoconstriction syndrome at the emergency department // Clin. Exp. Emerg. Med. — 2015. — 2(4). — P. 203-209.

Khazaie H., Resaie L., Payam N.R., Najafi F. Antidepressant — induced sexual dysfunction during treatment with fluoxetine, sertraline and trazodone; a randomized controlled trail // General Hospital Psychiatry. — 2015. — 37. — 40-45.

Lu S.R., Liao Y.C., Fuh J.L., Lirng J.F., Wang S.J. Nimodi­pine for treatment of primary thunderclap headache // Neurology. — 2004. — 62. — P.1414-16.

Marra A., Vargas M., Striano P. et al. Posterior reversible encephalopathy syndrome: the endothelial hypotheses // Med. Hypo­theses. — 2014. — 82. — P.619-22.

Marshall N., Maclaurin WA., Koulouris G. MRA captures vasospasm in fatal migrainous infarction // Headache. — 2007. — 47. — P. 280-83.

Miller T.R., Shivashankar R., Mossa-Basha M., Gandhi D. Reversible Cerebral Vasoconstriction Syndrome, Part 1: Epidemiology, Pathogenesis, and Clinical Course // Am. J. Neuroradiol. — 2015. — 36(8). — P. 1392-9.

Morrissette D.A., Stahl S.M. Modulating the serotonin system in the treatment of major depressive disorder-ERRATUM // NS Spectr. — 2015. — 20(4). — P. 452-3.

Nowak D.A., Rodiek S.O., Henneken S. et al. Reversible segmental cerebral vasoconstriction (Call-Fleming syndrome): are calcium channel inhibitors a potential treatment option? //

Cephalalgia. — 2003. — 23. — P. 218-22.

Probert R., Saunders D.E., Ganesan V. Reversible cerebral vasoconstriction syndrome: rare or underrecognized in children? // Dev. Med. Child Neurol. — 2013. — 55. — P. 385-89.

Razavi M., Bendixen B., Maley J.E. et al. CNS pseudovasculitis in a patient with pheochromocytoma // Neurology. — 1999. — 52. — P. 1088-90.

Rousseaux P., Scherpereel B., Bernard M.H., Guyot J.F. Acute benign cerebral angiopathy: 6 cases // Presse Med. — 1983. — 12. — P. 2163-68.

Sattar A., Manousakis G., Jensen M. B. Systematic review of reversible cerebral vasoconstriction syndrome // Expert Rev. Cardiovasc Ther. — 2010. — 8(10). — 1417-1421.

Serdaru M., Chiras J., Cujas M., Lhermitte F. Isolated benign cerebral vasculitis or migrainous vasospasm? // J. Neurol. Neurosurg. Psychiatry. — 1984. — 47. — P. 73-76.

Sheikh H.U., Mathew P.G. Reversible cerebral vasoconstriction syndrome: updates and new perspectives // Curr. Pain Headache Rep. — 2014. — 18. — P.414.

Singhal A.B. Cerebral vasoconstriction syndromes // Top Stroke Rehabil. — 2004. — 11. — P. 1-6.

Singhal A.B., Hajj-Ali R.A., Topcuoglu M.A. et al. Reversible cerebral vasoconstriction syndromes: analysis of 139 cases // Arch. Neurol. — 2011. — 68. — P. 1005-12.

Singhal AB. Postpartum angiopathy with reversible posterior leukoencephalopathy // Arch. Neurol. — 2004. — 61. — P. 411-16.

Singhal A.B., Topcuoglu M.A. Glucocorticoid associated worsening in reversible cerebral vasoconstriction syndrome // Neurology. — 2017. — 88(3). — P. 228-236.

Snyder B.D., McClelland R.R. Isolated benign cerebral vasculitis // Arch. Neurol. — 1978. — 35. — P. 612-14.

Stahl S.M., Lee-Zimmerman C., Cartwright S., Mor­rissette D.A. Serotonergic drugs for depression and beyond // Curr. Drug Targets. — 2013. — 14(5). — P. 578-85.

Stahl S.M. Mechanism of action of trazodone: a multifunctional drug // CNS Spectr. — 2009. — Vol. 14. — P. 536-46.

Wang S.J., Fuh J.L., Wu Z.A., Chen S.P., Lirng J.F. Bath-related thunderclap headache: a study of 21 consecutive patients // Cephalalgia. — 2008. — 28. — P. 524-30.

Williams T.L., Lukovits T.G., Harris B.T. et al. A fatal case of postpartum cerebral angiopathy with literature review // Arch. Gynecol. Obstet. — 2007. — 275. — P.67-77.

Wolff V., Lauer V., Rouyer O. et al. Cannabis use, ischemic stroke, and multifocal intracranial vasoconstriction: a prospective study in 48 consecutive young patients // Stroke. — 2011. — 42. — P. 1778-80.

Worrall B.B., Phillips C.D., Henderson K.K. Herbal energy drinks, phenylpropanoid compounds, and cerebral vasculopathy // Neurology. — 2005. — 65. — P. 1137-38.




Copyright (c) 2017 INTERNATIONAL NEUROLOGICAL JOURNAL

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2018

 

   Seo анализ сайта